|Recommendation: For patients with severe EGPA whose disease has entered remission, we conditionally recommend treatment with methotrexate, azathioprine, or mycophenolate mofetil over mepolizumab for remission maintenance.|20|Very low|
|Ungraded position statement: The duration of GC therapy in EGPA should be guided by the patientâ€™s clinical condition, values, and preferences.|21, 22, 23, 29, 30|Very low to low|
|Treatment of relapse| | |